Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Cleveland BioLabs Company Profile (NASDAQ:CBLI)

Consensus Ratings for Cleveland BioLabs (NASDAQ:CBLI) (?)
Ratings Breakdown: 2 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.57 (255.76% upside)

Analysts' Ratings History for Cleveland BioLabs (NASDAQ:CBLI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/24/2014Cantor FitzgeraldDowngradeBuy -> Hold$4.00 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
1/24/2014OppenheimerDowngradeOutperform -> Market Perform$0.75 -> $1.13ViewTweet This Rating  Share This Rating on StockTwits
3/20/2013Cantor FitzgeraldInitiated CoverageBuy$4.00ViewTweet This Rating  Share This Rating on StockTwits
12/6/2012OppenheimerInitiated CoverageOutperform$3.00ViewTweet This Rating  Share This Rating on StockTwits
12/4/2012Burrill Institutional ResearchInitiated CoverageOutperform$4.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/25/2012 forward)
Discuss Cleveland BioLabs